Status:
COMPLETED
Cardiovascular Effects of CART Cell Therapy
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Leukemia
Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study aiming to prospectively define the rate of occurrence, natural history and progression of cardiac dysfunction in adults, and to identify the patients at high risk of dev...
Detailed Description
Patients have echo, blood draw, and QoL survey prior to CART infusion, then 2 days, 1 week, 1 month and 6 months following CART infusion. If patients experiences CRS, study team acquires echo within 7...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Diagnosed with CD19+ malignancy undergoing treatment with CART cells
Exclusion
- Unable to provide informed consent
Key Trial Info
Start Date :
July 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 16 2022
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04026737
Start Date
July 22 2019
End Date
November 16 2022
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104